关注
Anas Maher Alsughayer
Anas Maher Alsughayer
Harvard Medical School
在 bidmc.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma
TN Aladily, A Mansour, A Alsughayer, M Sughayer, LJ Medeiros
Annals of Diagnostic Pathology 40, 72-76, 2019
192019
Comparison of 22C3 PharmDx and SP263 assays to test PD-L1 expression in NSCLC
MA Sughayer, F Alnaimy, AM Alsughayer, N Qamhia
Applied Immunohistochemistry & Molecular Morphology 27 (9), 663-666, 2019
132019
The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma
GN Al-Jussani, A Alsughayer, MS Yousuf, Y Mullahuwash, T Dabbagh, ...
The International Journal of Biological Markers 37 (3), 322-327, 2022
72022
Changing trends in estrogen receptors/progesterone receptors/human epidermal growth factor receptor 2 prevalence rates among Jordanian patients with breast cancer over the years
AM Alsughayer, TZ Dabbagh, RH Abdel-Razeq, GN Al-Jussani, ...
JCO global oncology 8, e2100359, 2022
32022
The utility of fascin and CD83 in the differential diagnosis of mediastinal large B-cell lymphomas
M Khader, TN Aladily, M Sughayer, A Alsughayer, RN Miranda, ...
VIRCHOWS ARCHIV 469 (SUPPL 1), S111-S111, 2016
22016
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity?
MA Sughayer, A Mansour, AA Nuirat, L Souan, R Abdel-Razeq, M Siag
medRxiv, 2021.08. 15.21261584, 2021
12021
The Value of Virtual Meetings during COVID-19 Pandemic in Healthcare Settings
MA Sughayer, TZ Dabbagh, L Souan, A Alsughayer
American Journal of Clinical Pathology 158 (Supplement_1), S127-S127, 2022
2022
Changing trends in hormone receptor and Her2 rates in breast cancer overtime
M Sughayer, H Abdel-Razeq, G Al-Jussania, A Alsughayer, T Dabbagh, ...
VIRCHOWS ARCHIV 479 (SUPPL 1), S73-S74, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–8